-
Reform the IOAS self-referral exception
ACLA and stakeholders ask Congress to support integrity in the practice of medicine and soften the blow to seniors by narrowing the IOAS exception, saving ... Read More -
ACLA Warns CMS’ Proposed Coding and Payment Proposals that Pose Draconian Cuts to Innovative Life-Saving Diagnostics Will Jeopardize the Advancement of Personalized Medicine
-
ACLA Expresses Serious Concerns About CMS’ Proposed Rule on Provisions in the Protecting Access to Medicare Act (PAMA)
-
Statement from the American Clinical Laboratory Association on the announcement by CMS of Appointees to the Advisory Panel on Clinical Diagnostic Laboratory Tests
-
ACLA Letter on Medicare Advantage Compliance Program Requirements for FDRs
-
ICD-10 Quick Start Guide
-
ACLA Letter to Senate Finance Committee on 6/3 WSJ Self-Referral Article
-
ACLA Letter to House Ways & Means Committee on 6/3 WSJ Self-Referral Article
-
ACLA Recognizes National Women’s Health Week by Spotlighting the Value of Diagnostic Testing as an Empowering Tool In Disease Prevention and Treatment Decision-Making
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today joined with the U.S. Department of Health and Human Services Office on Women’s Health to recognize ... Read More -
ACLA’s 20th Annual Conference Gathers Legal, Congressional & Regulatory Leaders on FDA’s Role with LDTs, Reimbursement and the Future of Personalized Medicine
WASHINGTON, DC – Scientists, physicians, researchers and lab clinicians will gather today in the nation’s capital to hear lawmakers, regulatory officials and legal experts address the ... Read More
